Establish of new deteciton of EGFR mutation status using immunostaining in non-small cell lung cancer
Project/Area Number |
23790425
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Human pathology
|
Research Institution | Kurume University |
Principal Investigator |
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
Fiscal Year 2013: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2012: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
Fiscal Year 2011: ¥780,000 (Direct Cost: ¥600,000、Indirect Cost: ¥180,000)
|
Keywords | 病理学 / 免疫染色 / EGFR遺伝子変異抗体 / 癌 / 遺伝子検査 / 病理 / EGFR 遺伝子変異 / 免疫組織・細胞化学 / 分子病理学 |
Research Abstract |
To establish a testing algorithm for EGFR mutation status in NSCLC patients, we utilized PNA-LNA PCR clamp assay and immunostaining. In the 133 samples, positive, negative and equivocal results for EGFR mutation-specific antibodies were observed in 37 patients (27.8%), 85 patients (63.9%) and 11 patients (8.3%), respectively. Thirty-seven patients showed positive EGFR expression by immunostaining, and 35 (94.6%) of these also tested positive in the DNA-based assay. Of 85 EGFR-negative patients by immunostaining, 77 (90.6%) also tested negative in the DNA-based assay. In NSCLC patients treated with EGFR-TKIs, the progression-free survival after the start of EGFR-TKIs treatment was significantly longer in patients with EGFR positive expression than in those with equivocal and negative expression (P = 0.002). Our results suggest immunostaining for EGFR mutation-specific antibodies are a new test for EGFR-TKI inhibition and could be a useful indicator with regard to patient management.
|
Report
(4 results)
Research Products
(57 results)
-
-
[Journal Article] Prognostic Value of EGFR Mutation and ERCC1 in Patients with Non-Small Cell Lung Cancer Undergoing Platinum-Based Chemotherapy.2013
Author(s)
Yamashita F, Azuma K, Yoshida T, Yamada K, Kawahara A, Hattori S, Takeoka H, Zaizen Y, Kawayama T, Kage M, Hoshino T.
-
Journal Title
PLoS ONE
Volume: 5
Issue: 8
Pages: e71356-e71356
DOI
Related Report
Peer Reviewed
-
-
-
[Journal Article] FOXP3 expression in tumor cells and tumor-infiltrating lymphocytes is associated with breast cancer prognosis2013
Author(s)
Miki Takenaka, Naoko Seki, Uhi Toh, Satoshi Hattori, Akihiko Kawahara, Tomohiko Yamaguchi, Keiko Koura, Ryuji Takahashi, Hiroko Otsuka, Hiroki Takahashi, Nobutaka Iwakuma, Shino Nakagawa, Teruhiko Fujii, Tetsuro Sasada, Rin Yamaguchi, Hirohisa Yano, Kazuo Shirouzu, Masayoshi Kage
-
Journal Title
Molecular and Clinical Oncology
Volume: 1
Issue: 4
Pages: 625-632
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Journal Article] Phase II study of personalized peptide vaccination for refractory bone and soft tissue sarcoma patients.2013
Author(s)
Takahashi R, Ishibashi Y, Hiraoka K, Matsueda S, Kawano K, Kawahara A, Kage M, Ohshima K, Yamanaka R, Shichijo S, Shirouzu K, Itoh K, Sasada T.
-
Journal Title
Cancer Sci.
Volume: 104
Issue: 10
Pages: 1285-1294
DOI
Related Report
Peer Reviewed
-
[Journal Article] Treatment outcome in patients with stage III breast cancer treated with neoadjuvant chemotherapy.2013
Author(s)
Takahashi R, Toh U, Iwakuma N, Mishima M, Fujii T, Takenaka M, Koura K, Seki N, Kawahara A, Kage M, Ogo E, Shirouzu K.
-
Journal Title
Experimental and therapeutic medicine
Volume: 6
Issue: 5
Pages: 1089-1095
DOI
Related Report
Peer Reviewed
-
[Journal Article] Potential usefulness of mucin immunohistochemical staining of preoperative pancreatic biopsy or juice cytology specimens in the determination of treatment strategies for intraductal papillary mucinous neoplasm.2013
Author(s)
Hisaka T, Horiuchi H, Uchida S, Ishikawa H, Kawahara R, Kawashima Y, Akashi M, Mikagi K, Ishida Y, Okabe Y, Nakayama M, Naito Y, Yano H, Taira T, Kawahara A, Kage M, Kinoshita H, Shirozu K.
-
Journal Title
Oncology Reports
Volume: 30
Issue: 5
Pages: 2035-2041
DOI
Related Report
Peer Reviewed
-
[Journal Article] A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer2012
Author(s)
Kawahara A, Taira T, Azuma K, Tominaga M, Hattori S, Kawahara M, Abe H, Yamaguchi T, Akiba J, Takamori S, Hayashi A, Kage M
-
Journal Title
Lung Cancer
Volume: 78巻
Issue: 1
Pages: 39-44
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] Chemotherapy for non-small cell lung cancer complicated by idiopathic interstitial pneumonia2012
Author(s)
Kinoshita T, Azuma K, Sasada T, Okamoto M, Hattori S, Imamura Y, Yamada K, Tajiri M, Yoshida T, Zaizen Y, Kawahara A, Fujimoto K, Hoshino T
-
Journal Title
Oncol Lett
Volume: 4巻
Issue: 3
Pages: 477-482
DOI
Related Report
Peer Reviewed
-
[Journal Article] Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.2012
Author(s)
Zaizen Y, Azuma K, Kurata S, Sadashima E, Hattori S, Sasada T, Imamura Y, Kaida H, Kawahara A, Kinoshita T, Ishibashi M, Hoshino T.
-
Journal Title
Eur J Radiol.
Volume: 81
Issue: 12
Pages: 4179-84
DOI
Related Report
Peer Reviewed
-
[Journal Article] Loss of Activating EGFR Mutant Gene Contributes to Acquired Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer Cells2012
Author(s)
Tabara K, Kanda R, Sonoda K, Kubo T, Murakami Y, Kawahara A, Azuma K, Abe H, Kage M, Yoshinaga A, Tahira T, Hayashi K, Arao T, Nishio K, Rosell R, Kuwano M, Ono M
-
Journal Title
PLoS One
Volume: 7巻
Issue: 7
Pages: e41017-e41017
DOI
Related Report
Peer Reviewed
-
[Journal Article] NDRG1/Cap43/Drg-1 may predict tumor angiogenesis and poor outcome in patients with lung cancer2012
Author(s)
Azuma, K., Kawahara, A., Hattori, S., Taira, T., Tsurutani, J., Watari, K., Shibata, T., Murakami, Y., Takamori, S., Ono, M., Izumi, H., Kage, M., Yanagawa, T., Nakagawa, K., Hoshino, T., Kuwano, M.
-
Journal Title
Journal of Thoracic Oncology
Volume: (In press)
Issue: 5
Pages: 779-789
DOI
Related Report
Peer Reviewed
-
-
[Journal Article] A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer.2012
Author(s)
Kawahara A, Taira T, Azuma K, Tominaga M, Hattori S, Kawahara M, Abe H, Yamaguchi T, Akiba J, Takamori S, Hayashi A, Kage M.
-
Journal Title
Lung Cancer.
Volume: 78
Pages: 39-44
Related Report
Peer Reviewed
-
[Journal Article] Association of the expression of mutant epidermal growth factor receptor protein as determined with mutation-specific antibodies in non-small cell lung cancer with progression-free survival after gefitinib treatment2011
Author(s)
Azuma, K., Okamoto, I., Kawahara, A., Taira, T., Nakashima, K., Hattori. S., Kinoshita, T., Takeda, M., Nakagawa, K., Takamori, S., Kuwano, M., Ono, M., Kage, M.
-
Journal Title
Journal of Thoracic Oncology
Volume: 6
Issue: 1
Pages: 122-127
DOI
Related Report
Peer Reviewed
-
[Journal Article] Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid : Rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry2011
Author(s)
Kawahara A, Azuma K, Sumi A, Taira T, Nakashima K, Aikawa E, Abe H, Yamaguchi T, Takamori S, Akiba J, Kage M
-
Journal Title
Lung Cancer
Volume: 74巻
Issue: 1
Pages: 35-40
DOI
Related Report
Peer Reviewed
-
-
-
[Presentation] Integrin beta1/Src/Akt-driven Bypass Signaling Pathway confers EGFR-TKI Resistance in Lung Cancer Cells2013
Author(s)
Mayumi Ono, Rina Kanda, Kosuke Watari, Kahori Sonoda, Masashi, Maeda, Yuichi Murakami, Akihiko Kawahara, Masayoshi Kage, Hidetaka Uramoto, Michihiko Kuwano
Organizer
72th Annual Meeting of the Japanese Cancer Association
Place of Presentation
Yokohama
Year and Date
2013-10-03
Related Report
-
-
-
[Presentation] 液状気管支細胞診を用いた肺癌診断2013
Author(s)
福満千容,河原明彦,多比良朋希,山口知彦,安倍秀幸,吉田友子,髙瀨頼妃呼,秋葉純,谷川健,鹿毛政義
Organizer
第54回日本臨床細胞学会総会
Place of Presentation
東京
Year and Date
2013-06-02
Related Report
-
-
-
-
-
-
-
-
-
-
[Presentation] Integrin beta1/Src/Akt-driven Bypass Signaling Pathway confers EGFR-TKI Resistance in Lung Cancer Cells.2013
Author(s)
Mayumi Ono, Rina Kanda, Kosuke Watari, Kahori Sonoda, Masashi, Maeda, Yuichi Murakami, Akihiko Kawahara, Masayoshi Kage, Hidetaka Uramoto, Michihiko Kuwano.
Organizer
72th Annual Meeting of the Japanese Cancer Association
Place of Presentation
Yokohama
Related Report
-
-
-
-
-
-
-
-
-
[Presentation] Interleukin 1 promotes lymph node metastasis by lung cancer cells through modification of tumor stroma cells2012
Author(s)
Tomohiro Shibata, Kosuke Watari, Akihiko Kawahara, Yuichi Murakami, Hiroshi Nabeshima, Koichi Azuma, Masayoshi Kage, Naofumi Mukaida, Michihiko Kuwano, Takashi Takahashi, Mayumi Ono
Organizer
71th Annual Meeting of the Japanese Cancer Association
Place of Presentation
71th Annual Meeting of the Japanese Cancer Association
Year and Date
2012-09-21
Related Report
-
-
-
-
-
-
-
-